AstraZeneca Pulls C-19 VVV After Admitting Rare Side Effect

AstraZeneca Pulls COVID Vaccine After Admitting Rare Side Effect

The withdrawal follows months of intense scrutiny over a rare side effect


In yet another damning development for the ‘safe and effective’ crowd, AstraZeneca has announced the worldwide withdrawal of its Oxford-AstraZeneca vaccine, branded as Vaxzevria, due to a rare but serious side effect. This decision marks the end of the vaccine once hailed as a “triumph for British science” by Boris Johnson and credited with saving over six million lives, The Telegraph reports.

The pharmaceutical giant voluntarily withdrew its “marketing authorization” in the European Union earlier this week, with similar actions expected soon in the UK and other approving countries. The move, described by the company as driven by “commercial reasons,” coincides with the availability of newer vaccines designed to combat emerging variants.

That said, the timing of the withdrawal follows months of intense scrutiny over a rare side effect. In a recent High Court document, the company admitted that Vaxzevria could, in very rare instances, cause Thrombosis with Thrombocytopenia Syndrome (TTS), which has been linked to at least 81 deaths in the UK. Despite these admissions, AstraZeneca maintains that the decision to pull the vaccine is unrelated to the ongoing legal challenges or its potential side effects.

“We are incredibly proud of the role Vaxzevria played in ending the global pandemic. According to independent estimates, over 6.5 million lives were saved in the first year of use alone and over three billion doses were supplied globally,” the company said in a statement. “Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic.”

The European Medicines Agency has begun the process to formally withdraw the vaccine, reflecting an expected move away from monovalent vaccines, which target only the original COVID-19 strain. Marco Cavaleri, head of vaccines at the agency, emphasized that this is a standard procedure for vaccines that are no longer in use.

Legal experts and victims, however, see the withdrawal as a vindication of their long-held concerns over the vaccine’s safety. “To those who we represent, all of whom have suffered bereavement or serious injury as a result of the AstraZeneca vaccine, this decision to withdraw marketing authorisation, ending the usage of the AstraZeneca vaccine in the EU, will be welcomed,” said Sarah Moore, a partner at Leigh Day, the law firm representing many of the claimants.

“It will be seen as a decision linked with AstraZeneca’s recent admission that the vaccine can cause TTS, and the fact that regulators across the world suspended or stopped usage of the vaccine following concerns regarding TTS.”

Victims and their families have reported a range of severe reactions, from fatal thrombosis to lasting disabilities, sparking a debate over the adequacy of vaccine safety monitoring and compensation for vaccine injuries.

Kate Scott, whose husband suffered a permanent brain injury after receiving the vaccine, expressed mixed feelings: “AstraZeneca’s Covid vaccine no longer being used in the UK or Europe, and soon the rest of the world, means no one else will suffer from this awful adverse reaction,” she said. “They say it is for commercial reasons, but maybe it’s because it can no longer be seen as being within the acceptable safety parameters, with 445 confirmed cases of VITT, 81 of these fatal in the UK alone.

Mr Scott, pictured with his wife, wishes the vaccine had been withdrawn much earlier Credit: ANDREW FOX via The Telegraph

The government’s vaccine damage payment scheme has been criticized for not providing sufficient compensation, prompting calls for reform. “This is an important regulatory step, but still our clients remain without fair compensation.

We will continue to fight for the compensation our clients need and campaign for reform of the vaccine damage payment scheme.,” Moore added.



Systematic Review Reveals Many COVID-19 Vaccine Recipients Experienced New-Onset Psychosis

Excess Deaths In Japan Hit 115,000 Following 3rd COVID Shot; New Study Explains Why


(TLB) published this article from ZH as posted by Tyler Durden

Header featured image (edited) credit: Lady holding vile/GETTY IMAGES EUROPE/MATTHEW HORWOOD

Emphasis added by (TLB)



Stay tuned tuned…


The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.